Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
6609 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2024-12-13 (harvard.edu)
Climate Resilience for Frontline Clinics Toolkit | Climate Resilience for Frontline Clinics and the Patients They Serve | T.H. Chan School of Public Health
The Climate Resilience for Frontline Clinics toolkit, developed in collaboration with Americares, helps protect people on the front lines of climate change.
Read more
2024-06-28 (hallandsposten.se)
No time to lose in climate change
With new technology, you can collect the carbon dioxide that goes up in smoke, and create the conditions for a new branch of Swedish industry.
Read more
2023-10-17 (e-fundresearch.com)
Amundi CPR Climate Action
Traditionally, the major US banks begin the reporting season that is now underway in the USA. At the
Read more
2022-05-03 (wytv.com)
Change at the top for Biogen after Alzheimer’s drug flops
Biogen will replace its CEO and largely abandon marketing of its controversial Alzheimer’s drug Aduhelm less than a year after the medication’s launch triggered a backlash from experts, doctors and insurers.
Read more
(csrwire.com)
Biogen Charts Second Year of Progress for Healthy Climate, Healthy Lives Initiative
In year two, we convened a Scientific Advisory Council to guide our program, analyzed the environmental impact of another three products, and strengthened our plan to reduce scope 3 emissions.
Read more